Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy

Journal of Urology

Volumn 150, Issue 3, 1993, Pages 908-913

  Dupont, A ^a   Gomez, J L ^a   Cusan, L ^a   Koutsilieris, M ^a   Labrie, F ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

antigens, neoplasm; flutamide; gonadorelin; prostatic neoplasms

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ANTIANDROGEN; FLUTAMIDE; GONADORELIN; NILUTAMIDE; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CASTRATION; CLINICAL ARTICLE; DOSE RESPONSE; DRUG RESISTANCE; DRUG WITHDRAWAL; HORMONAL REGULATION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0027249588     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)35646-X     Document Type: Article

References (0)